ArticleChemistry & biodiversity2026
The Metabolites Produced by Citrus reticulata-Derived Endophyte Aspergillus fumigatus as Potential Antifungal Agents Against Citrus Pathogens.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Six new bergamotene sesquiterpenoids (1-6), one new cyclohexenone derivative (7), and nine known compounds (8-16) were isolated from Citrus reticulata-associated endophytic fungus Aspergillus fumigatus. The structures were systematically established mainly by NMR data, HRESIMS, DP4+ analysis, and ECD calculations. Compounds 2-6 were proposed to be derived from β-trans-bergamotene via C-5/C-6 skeletal cleavage and further modifications. Among them, compounds 2 and 3 represent the first reported instances of the β-bergamotene derivatives bearing an epoxide moiety, characterized by unique 6/5/3 and 6/6/3 tricyclic frameworks based on oxabicyclo[3.2.1]octane and oxabicyclo[3.3.1]nonane cores, respectively. Antifungal activities against two citrus pathogens, Fusarium graminearum and Alternaria alternata, revealed that most compounds exhibited significant antifungal activities, with MIC values of 1-8 µg/mL. Notably, the antifungal activities of compounds 8 and 9 against A. alternata and compound 14 against F. graminearum were comparable to those of nystatin.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.